Logo image of PRLB

PROTO LABS INC (PRLB) Stock Fundamental Analysis

NYSE:PRLB - New York Stock Exchange, Inc. - US7437131094 - Common Stock - Currency: USD

41.17  +0.44 (+1.08%)

After market: 41.17 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to PRLB. PRLB was compared to 128 industry peers in the Machinery industry. PRLB has a great financial health rating, but its profitability evaluates not so good. PRLB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

PRLB had positive earnings in the past year.
In the past year PRLB had a positive cash flow from operations.
PRLB had positive earnings in 4 of the past 5 years.
Each year in the past 5 years PRLB had a positive operating cash flow.
PRLB Yearly Net Income VS EBIT VS OCF VS FCFPRLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

PRLB's Return On Assets of 2.02% is on the low side compared to the rest of the industry. PRLB is outperformed by 60.16% of its industry peers.
The Return On Equity of PRLB (2.27%) is worse than 63.28% of its industry peers.
PRLB's Return On Invested Capital of 2.21% is on the low side compared to the rest of the industry. PRLB is outperformed by 67.97% of its industry peers.
PRLB had an Average Return On Invested Capital over the past 3 years of 2.43%. This is significantly below the industry average of 10.71%.
Industry RankSector Rank
ROA 2.02%
ROE 2.27%
ROIC 2.21%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
PRLB Yearly ROA, ROE, ROICPRLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

With a Profit Margin value of 2.99%, PRLB perfoms like the industry average, outperforming 42.19% of the companies in the same industry.
PRLB's Profit Margin has declined in the last couple of years.
The Operating Margin of PRLB (4.64%) is worse than 63.28% of its industry peers.
PRLB's Operating Margin has declined in the last couple of years.
The Gross Margin of PRLB (44.36%) is better than 81.25% of its industry peers.
PRLB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.64%
PM (TTM) 2.99%
GM 44.36%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
PRLB Yearly Profit, Operating, Gross MarginsPRLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

9

2. Health

2.1 Basic Checks

PRLB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
PRLB has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, PRLB has less shares outstanding
The debt/assets ratio for PRLB has been reduced compared to a year ago.
PRLB Yearly Shares OutstandingPRLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
PRLB Yearly Total Debt VS Total AssetsPRLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

PRLB has an Altman-Z score of 8.73. This indicates that PRLB is financially healthy and has little risk of bankruptcy at the moment.
PRLB's Altman-Z score of 8.73 is amongst the best of the industry. PRLB outperforms 91.41% of its industry peers.
The Debt to FCF ratio of PRLB is 0.01, which is an excellent value as it means it would take PRLB, only 0.01 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of PRLB (0.01) is better than 93.75% of its industry peers.
PRLB has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, PRLB belongs to the top of the industry, outperforming 85.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 8.73
ROIC/WACC0.22
WACC9.89%
PRLB Yearly LT Debt VS Equity VS FCFPRLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 3.13 indicates that PRLB has no problem at all paying its short term obligations.
PRLB has a better Current ratio (3.13) than 78.13% of its industry peers.
PRLB has a Quick Ratio of 2.92. This indicates that PRLB is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of PRLB (2.92) is better than 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 3.13
Quick Ratio 2.92
PRLB Yearly Current Assets VS Current LiabilitesPRLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

The earnings per share for PRLB have decreased by -8.24% in the last year.
The earnings per share for PRLB have been decreasing by -10.19% on average. This is quite bad
The Revenue has decreased by -1.33% in the past year.
PRLB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.78% yearly.
EPS 1Y (TTM)-8.24%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%-17.5%
Revenue 1Y (TTM)-1.33%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%-1.32%

3.2 Future

Based on estimates for the next years, PRLB will show a decrease in Earnings Per Share. The EPS will decrease by -0.91% on average per year.
Based on estimates for the next years, PRLB will show a small growth in Revenue. The Revenue will grow by 3.54% on average per year.
EPS Next Y-14.33%
EPS Next 2Y-0.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.47%
Revenue Next 2Y3.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PRLB Yearly Revenue VS EstimatesPRLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
PRLB Yearly EPS VS EstimatesPRLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 26.39, the valuation of PRLB can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as PRLB.
PRLB is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
PRLB is valuated quite expensively with a Price/Forward Earnings ratio of 25.73.
PRLB's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. PRLB is more expensive than 62.50% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.90. PRLB is around the same levels.
Industry RankSector Rank
PE 26.39
Fwd PE 25.73
PRLB Price Earnings VS Forward Price EarningsPRLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PRLB is on the same level as its industry peers.
PRLB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PRLB is cheaper than 81.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.6
EV/EBITDA 14.82
PRLB Per share dataPRLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.91%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PRLB!.
Industry RankSector Rank
Dividend Yield N/A

PROTO LABS INC

NYSE:PRLB (7/3/2025, 8:01:27 PM)

After market: 41.17 0 (0%)

41.17

+0.44 (+1.08%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)08-01 2025-08-01/bmo
Inst Owners93.25%
Inst Owner Change-50.48%
Ins Owners1.05%
Ins Owner Change3.43%
Market Cap978.61M
Analysts76.36
Price Target45.9 (11.49%)
Short Float %3.31%
Short Ratio3.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.65%
Min EPS beat(2)10.87%
Max EPS beat(2)16.42%
EPS beat(4)4
Avg EPS beat(4)19.58%
Min EPS beat(4)7.67%
Max EPS beat(4)43.37%
EPS beat(8)8
Avg EPS beat(8)28.54%
EPS beat(12)11
Avg EPS beat(12)24.23%
EPS beat(16)13
Avg EPS beat(16)20.86%
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-0.63%
Max Revenue beat(2)0.02%
Revenue beat(4)2
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-2.44%
Max Revenue beat(4)1.46%
Revenue beat(8)4
Avg Revenue beat(8)0.08%
Revenue beat(12)6
Avg Revenue beat(12)0.05%
Revenue beat(16)7
Avg Revenue beat(16)-0.07%
PT rev (1m)0%
PT rev (3m)1.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.91%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.53%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)0.66%
Valuation
Industry RankSector Rank
PE 26.39
Fwd PE 25.73
P/S 1.96
P/FCF 14.6
P/OCF 13.07
P/B 1.49
P/tB 2.7
EV/EBITDA 14.82
EPS(TTM)1.56
EY3.79%
EPS(NY)1.6
Fwd EY3.89%
FCF(TTM)2.82
FCFY6.85%
OCF(TTM)3.15
OCFY7.65%
SpS21
BVpS27.63
TBVpS15.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.02%
ROE 2.27%
ROCE 3.43%
ROIC 2.21%
ROICexc 2.58%
ROICexgc 5.26%
OM 4.64%
PM (TTM) 2.99%
GM 44.36%
FCFM 13.43%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
ROICexc(3y)2.8%
ROICexc(5y)3.78%
ROICexgc(3y)5.45%
ROICexgc(5y)6.71%
ROCE(3y)3.77%
ROCE(5y)4.91%
ROICexcg growth 3Y-8.13%
ROICexcg growth 5Y-18.97%
ROICexc growth 3Y-4.98%
ROICexc growth 5Y-24.03%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 22.16%
Cap/Sales 1.57%
Interest Coverage 250
Cash Conversion 127.85%
Profit Quality 449.12%
Current Ratio 3.13
Quick Ratio 2.92
Altman-Z 8.73
F-Score6
WACC9.89%
ROIC/WACC0.22
Cap/Depr(3y)51.87%
Cap/Depr(5y)76.84%
Cap/Sales(3y)3.95%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.24%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%-17.5%
EPS Next Y-14.33%
EPS Next 2Y-0.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.33%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%-1.32%
Revenue Next Year2.47%
Revenue Next 2Y3.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-26.12%
EBIT growth 3Y-14.15%
EBIT growth 5Y-20.42%
EBIT Next Year53.89%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.28%
FCF growth 3Y48.42%
FCF growth 5Y4.96%
OCF growth 1Y11.91%
OCF growth 3Y12.13%
OCF growth 5Y-7.69%